Shanghai Shyndec Pharmaceutical Co Ltd (600420) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥486.04 Million ≈ $71.12 Million USD) by net assets (CN¥15.70 Billion ≈ $2.30 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Shyndec Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Shanghai Shyndec Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Shanghai Shyndec Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Shyndec Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Shyndec Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Shanghai Shyndec Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
GIMV NV
BR:GIMB
-0.116x
Gestamp Automocion SA
MC:GEST
0.122x
Ruentex Engineering & Construction Co Ltd
TW:2597
-0.059x
EQ Resources Ltd
AU:EQR
-0.169x
Der International Home Furnishing Co Ltd
SHE:002631
-0.007x
ORG Packaging Co Ltd
SHE:002701
0.068x
Atrium Ljungberg AB (publ)
ST:ATRLJ-B
0.005x
Anterix Inc
NASDAQ:ATEX
0.007x

Annual Cash Flow Conversion Efficiency for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. View Shanghai Shyndec Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥34.93 Billion
≈ $5.11 Billion
CN¥1.70 Billion
≈ $248.48 Million
0.049x -66.98%
2024-12-31 CN¥15.32 Billion
≈ $2.24 Billion
CN¥2.26 Billion
≈ $330.12 Million
0.147x +22.71%
2023-12-31 CN¥14.34 Billion
≈ $2.10 Billion
CN¥1.72 Billion
≈ $251.74 Million
0.120x -48.94%
2022-12-31 CN¥12.15 Billion
≈ $1.78 Billion
CN¥2.86 Billion
≈ $417.87 Million
0.235x +45.07%
2021-12-31 CN¥10.37 Billion
≈ $1.52 Billion
CN¥1.68 Billion
≈ $245.79 Million
0.162x +1.94%
2020-12-31 CN¥9.82 Billion
≈ $1.44 Billion
CN¥1.56 Billion
≈ $228.30 Million
0.159x +15.13%
2019-12-31 CN¥9.20 Billion
≈ $1.35 Billion
CN¥1.27 Billion
≈ $185.86 Million
0.138x -30.19%
2018-12-31 CN¥8.44 Billion
≈ $1.24 Billion
CN¥1.67 Billion
≈ $244.25 Million
0.198x -34.68%
2017-12-31 CN¥7.65 Billion
≈ $1.12 Billion
CN¥2.31 Billion
≈ $338.69 Million
0.303x +150.41%
2016-12-31 CN¥6.94 Billion
≈ $1.02 Billion
CN¥838.58 Million
≈ $122.71 Million
0.121x -14.06%
2015-12-31 CN¥1.61 Billion
≈ $235.83 Million
CN¥226.65 Million
≈ $33.17 Million
0.141x -24.27%
2014-12-31 CN¥1.39 Billion
≈ $203.72 Million
CN¥258.51 Million
≈ $37.83 Million
0.186x +18.60%
2013-12-31 CN¥1.33 Billion
≈ $193.92 Million
CN¥207.50 Million
≈ $30.36 Million
0.157x -3.62%
2012-12-31 CN¥1.19 Billion
≈ $174.21 Million
CN¥193.41 Million
≈ $28.30 Million
0.162x +13.10%
2011-12-31 CN¥947.63 Million
≈ $138.67 Million
CN¥136.12 Million
≈ $19.92 Million
0.144x +4.53%
2010-12-31 CN¥837.59 Million
≈ $122.57 Million
CN¥115.11 Million
≈ $16.84 Million
0.137x +0.63%
2009-12-31 CN¥713.46 Million
≈ $104.40 Million
CN¥97.43 Million
≈ $14.26 Million
0.137x +48.57%
2008-12-31 CN¥631.47 Million
≈ $92.40 Million
CN¥58.04 Million
≈ $8.49 Million
0.092x -33.63%
2007-12-31 CN¥594.29 Million
≈ $86.96 Million
CN¥82.31 Million
≈ $12.04 Million
0.138x -3.74%
2006-12-31 CN¥511.49 Million
≈ $74.85 Million
CN¥73.60 Million
≈ $10.77 Million
0.144x +19.00%
2005-12-31 CN¥478.84 Million
≈ $70.07 Million
CN¥57.90 Million
≈ $8.47 Million
0.121x +213.99%
2004-12-31 CN¥441.88 Million
≈ $64.66 Million
CN¥17.02 Million
≈ $2.49 Million
0.039x --

About Shanghai Shyndec Pharmaceutical Co Ltd

SHG:600420 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.65 Billion
CN¥11.27 Billion CNY
Market Cap Rank
#6942 Global
#1469 in China
Share Price
CN¥8.40
Change (1 day)
+0.36%
52-Week Range
CN¥7.78 - CN¥10.97
All Time High
CN¥17.27
About

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provides nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and… Read more